Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1472 results

Health status after transcatheter vs. surgical aortic valve replacement in low-risk patients with aortic stenosis

05 Dec 2019

Although multiple studies have demonstrated an early health status benefit with TAVI vs. SAVR , this is the first randomized trial to demonstrate a persistent, albeit modest, health status advantage with TAVI at 6 and 12 months—timepoints at which patients are assumed to have recovered fully...

Reviewer

Salvatore Brugaletta
Health status after transcatheter vs. surgical aortic valve replacement in low-risk patients with aortic stenosis

Prosthesis-patient mismatch following transcatheter aortic valve replacement with supra-annular and intra-annular prostheses

03 Dec 2019

The results of this study suggest that the use of self-expandable valves could help reduce the incidence of post-procedural PPM after TAVI, especially in the population with large body size...

Reviewer

Romain Didier
Souheib Feliachi

Reviewer

Souheib Feliachi
Prosthesis-patient mismatch following TAVR with supra-annular and intra-annular prostheses

Reduced leaflet motion after transcatheter aortic-valve replacement

27 Nov 2019

The GALILEO-4D was a dedicated substudy that sought to evaluate the effect of oral anticoagulation with rivaroxaban on bioprosthetic aortic valve leaflet thickening and motion impairment.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Antonio H. Frangieh

Reviewer

Antonio H. Frangieh
Reduced leaflet motion after transcatheter aortic-valve replacement

Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement

05 Dec 2019

Using the data from the national prospective French registry (FRANCE TAVI), this study compared the characteristics and outcomes of TAVR procedures according to whether they were performed through a femoral or a nonfemoral peripheral access.

Reviewer

Salvatore Brugaletta
Femoral vs nonfemoral peripheral access for transcatheter aortic valve replacement

TAVI in bicuspid aortic valve disease

26 Nov 2019

Watch the video on demand with leading experts Bernard Prendergast, Markus Kasel and Won-Keun Kim

View the replay of this PCR Webinar on TAVI in bicuspid aortic valve disease

Impella vs. balloon pump, COLCOT, RECOVERY… reported from AHA 2019 in Philadelphia

19 Nov 2019

Mirvat Al Asnag and Francesco Costa present a brief overview of Impella vs. balloon pump, COLCOT, and RECOVERY trials presented at the AHA 2019 in Philadelphia...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Francesco Costa

Author

Francesco Costa
Impella vs. balloon pump, COLCOT, RECOVERY… reported from AHA 2019 in Philadelphia

TAVI: management of unusual complications

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn more about how to manage the following unusual TAVI complications: wire entrapment in hypertrabecular left ventricle after aortic valve release, iatrogenic VSD after TAVI in a patient with bicuspid severe aortic stenosis, ruptured pseudoaneurysm of the mitral-aortic intervalvular fibrosa, unsuccessful TAVI in...

TAVI: management of unusual complications

Treatment of aortic stenosis for today - Important considerations for the future

Consult this session to learn more about some important considerations when selecting your TAVI device, how innovations drive improvement in procedural and clinical outcomes, and discover various procedural techniques using the latest generation TAVI system, such as Portico IDE FlexNav, NAVITOR next-gen self-expanding valve, and more!

Treatment of aortic stenosis for today - Important considerations for the future

TAVI in patients with associated disease of the aorta

19 Nov 2019 – From PCR London Valves 2019

Consult this session on TAVI in patients with associated disease of the aorta to discover various challenging clinical cases: transapical revalving in type B aortic dissection, abdominal aortic rupture treatment during TAVI, double TEVAR for aortic aneurysm and type A aortic dissection, and more!

TAVI in patients with associated disease of the aorta

Complications of surgical and transcatheter valve interventions: the case that taught me most

19 Nov 2019 – From PCR London Valves 2019

Consult this session on the complications of surgical and transcatheter valve interventions to learn tips and tricks from high-volume experienced operators, and to discover techniques for an effective prevention and management of life-threatening complications.

Complications of surgical and transcatheter valve interventions: the case that taught me most

Case-based learning for the Heart Valve Team: TAVI in failing surgical bioprostheses - Not always as easy as it looks

19 Nov 2019 – From PCR London Valves 2019

Consult this session to discover how an awareness of bioprosthetic valve characteristics is essential for valve-in-valve device selection and implantation, how careful preparation and peri-procedural imaging are essential to predict and prevent life-threatening complications, and learn key procedural tips and tricks for a safe and successful valve-in-valve TAVI procedure.

Case-based learning for the Heart Valve Team: TAVI in failing surgical bioprostheses

TAV in TAV for an 8-year old degenerating TAVI device - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom

TAV in TAV for an 8-year

Case-based learning for the Heart Valve team: TAVI failure - What are the options?

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn more about the detection and management of structural valve deterioration and bioprosthetic valve failure, and discover the key role of imaging in patient assessment, with a selection of challenging clinical cases: a TAVI patient with structural valve deterioration, another one with infective endocarditis, and more!

Case-based learning for the Heart Valve team: TAVI failure - What are the options?

TAVI in bicuspid aortic valve disease - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with LIVE demonstration from Clinique Pasteur - Toulouse, France

TAVI in bicuspid aortic

TAVI in unusual clinical situations

19 Nov 2019 – From PCR London Valves 2019

Consult this session to discover various interesting cases, involving TAVI in unusual clinical situations, such as in long-term ventricular assist device supported patient, in pure aortic regurgitation and advanced liver and kidney failure, and more!

TAVI in unusual clinical situations

Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation

19 Nov 2019 – From PCR London Valves 2019

Consult this session on TAVI in pure aortic regurgitation to learn more about the anatomy and pathophysiology of aortic regurgitation, the current and emerging surgical treatment options, and the potential role of TAVI in this patient group and how to identify potential candidates for transcatheter intervention.

Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation

What will be relevant for TAVI assessment in 2020?

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about what will be relevant for TAVI assessment in 2020: key imaging requirements before referral to the Heart Team, which patients may need a pacemaker and when it should be implanted, how modern Heart Teams should function, and more!

What will be relevant for TAVI assessment in 2020?

Long-term clinical outcomes after SAVR and TAVI

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about the long-term clinical outcomes after SAVR and TAVI, thanks to a variety of studies and registries: BIVOLUT-X, STS/ACC TVT, and more!

Long-term clinical outcomes after SAVR and TAVI

Heart Team 2.0 in action: how to manage complex TAVI procedures

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn how to plan a successful TAVI procedure for your patients with challenging anatomy and high-risk clinical characteristics, such as: with a bicuspid aortic valve and associated aortopathy, with severe LVOT calcification, with a high risk of left main coronary occlusion, and more!

Heart Team 2.0 in action: how to manage complex TAVI procedures

Will PARTNER-3 and Evolut low-risk trials change my practice?

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.

Will PARTNER-3 and Evolut low-risk trials change my practice?